recall
saveZydus Pharmaceuticals (USA) Inc recall (Cls II)
community read0 votes
Icosapent Ethyl capsules, 1 gram, 120-count bottles, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1592-07 — Reason: Subpotent Drug: Due oxidation caused by leakage of the contents of the Icosapent Ethyl 1g capsules. Use of the affected product may lead to inconsistent therapeutic effects and an increase in potential gastrointestinal side effects in some patients. — Status: Ongoing
view source ↗Data sources
last refreshed 6m ago
Found something off?
same company · ±60 days · 6
- recallGranules Pharmaceuticals Inc. recall (Cls II)Feb 11, 2026
- recallGlenmark Pharmaceuticals Inc., USA recall (Cls II)Jan 7, 2026
- recallZydus Pharmaceuticals (USA) Inc recall (Cls III)Jan 7, 2026
- recallLupin Pharmaceuticals Inc. recall (Cls II)Dec 17, 2025
- recallLupin Pharmaceuticals Inc. recall (Cls II)Dec 17, 2025
- recallGlenmark Pharmaceuticals Inc., USA recall (Cls III)Dec 17, 2025
comments(0)
5-min edit window · permanent after that